Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuanzi Ye

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
BMC Cancer|November 6, 2016
Temporal trends in the risk of developing multiple primary cancers: a systematic reviewYuanzi Ye, Amanda L Neil, Karen E Wills, et al.
International Journal of Medicinal Mushrooms|February 6, 2025
Effects of Lingzhi or Reishi Medicinal Mushroom Ganoderma lucidum (Agaricomycetes) Triterpene on Motor and Spatial Learning Disorders in 5xFAD MiceChang Zhang, Yuanzi Ye, Weiyao Wang, et al.
BMC Cancer|November 27, 2020
Effects of reduced platelet count on the prognosis for patients with non-small cell lung cancer treated with EGFR-TKI: a retrospective studyLu Xu, Fangzhou Xu, Haobo Kong, et al.
Cancer|January 26, 2018
Temporal trends in the risk of second primary cancers among survivors of adult-onset cancers, 1980 through 2013: An Australian population-based studyYuanzi Ye, Petr Otahal, Karen E Wills, et al.
Cancer Epidemiology|May 27, 2018
Temporal trends in competing mortality from second and subsequent primary cancers, 1980-2014: An Australian population-based studyYuanzi Ye, Petr Otahal, Karen E Wills, et al.
Journal of Cancer|April 15, 2020
Surgery on primary tumor shows survival benefit in selected stage IV colon cancer patients: A real-world study based on SEER databaseJing Xu, Tai Ma, Yuanzi Ye, et al.
Medicine|August 31, 2022
Excellent response of lung adenocarcinoma harboring a rare SLC8A1 downstream intergenic region ALK fusion to ceritinib treatment: A case reportLei Fang, Guozheng Ding, Muzi Wang, et al.
Cancer|October 13, 2018
Cardiovascular and other competing causes of death among patients with cancer from 2006 to 2015: An Australian population-based studyYuanzi Ye, Petr Otahal, Thomas H Marwick, et al.
Drug Delivery|December 29, 2021
Co-delivery of paclitaxel (PTX) and docosahexaenoic acid (DHA) by targeting lipid nanoemulsions for cancer therapyBo Li, Tingfei Tan, Weiwei Chu, et al.
Pathology, Research and Practice|May 29, 2024
Clinicopathological and molecular characterization of resected lung adenocarcinoma: Correlations with histopathological grading systems in Chinese patientsWanli Xia, Siyuan Zhang, Yuanzi Ye, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
BMC Cancer|November 6, 2016
Temporal trends in the risk of developing multiple primary cancers: a systematic reviewYuanzi Ye, Amanda L Neil, Karen E Wills, et al.
International Journal of Medicinal Mushrooms|February 6, 2025
Effects of Lingzhi or Reishi Medicinal Mushroom Ganoderma lucidum (Agaricomycetes) Triterpene on Motor and Spatial Learning Disorders in 5xFAD MiceChang Zhang, Yuanzi Ye, Weiyao Wang, et al.
BMC Cancer|November 27, 2020
Effects of reduced platelet count on the prognosis for patients with non-small cell lung cancer treated with EGFR-TKI: a retrospective studyLu Xu, Fangzhou Xu, Haobo Kong, et al.
Cancer|January 26, 2018
Temporal trends in the risk of second primary cancers among survivors of adult-onset cancers, 1980 through 2013: An Australian population-based studyYuanzi Ye, Petr Otahal, Karen E Wills, et al.
Cancer Epidemiology|May 27, 2018
Temporal trends in competing mortality from second and subsequent primary cancers, 1980-2014: An Australian population-based studyYuanzi Ye, Petr Otahal, Karen E Wills, et al.
Journal of Cancer|April 15, 2020
Surgery on primary tumor shows survival benefit in selected stage IV colon cancer patients: A real-world study based on SEER databaseJing Xu, Tai Ma, Yuanzi Ye, et al.
Medicine|August 31, 2022
Excellent response of lung adenocarcinoma harboring a rare SLC8A1 downstream intergenic region ALK fusion to ceritinib treatment: A case reportLei Fang, Guozheng Ding, Muzi Wang, et al.
Cancer|October 13, 2018
Cardiovascular and other competing causes of death among patients with cancer from 2006 to 2015: An Australian population-based studyYuanzi Ye, Petr Otahal, Thomas H Marwick, et al.
Drug Delivery|December 29, 2021
Co-delivery of paclitaxel (PTX) and docosahexaenoic acid (DHA) by targeting lipid nanoemulsions for cancer therapyBo Li, Tingfei Tan, Weiwei Chu, et al.
Pathology, Research and Practice|May 29, 2024
Clinicopathological and molecular characterization of resected lung adenocarcinoma: Correlations with histopathological grading systems in Chinese patientsWanli Xia, Siyuan Zhang, Yuanzi Ye, et al.
Pageof 2